“Rising Demand for At-Home Diagnostic Testing and Microcollection Technologies”
- A key and accelerating trend in the North America capillary blood collection and sampling devices market is the growing adoption of home-based diagnostic testing, driven by rising consumer demand for convenience, cost-efficiency, and accessibility in healthcare delivery. This trend is supported by innovations in microcollection devices that allow accurate sample collection with minimal discomfort and training
- For instance, companies such as Neoteryx and Tasso have introduced user-friendly microsampling devices that enable remote blood collection through volumetric absorptive microsampling (VAMS) and push-button systems, eliminating the need for in-clinic visits. These devices are gaining traction in chronic disease monitoring, pharmacokinetics, and decentralized clinical trials
- In addition, technological advances in sample preservation, such as dried blood spot (DBS) and VAMS, support the stability and transport of specimens for lab analysis, further fueling the demand for remote testing solutions
- Integration with digital health platforms allows seamless transmission of diagnostic data from remote collection sites to laboratories or healthcare providers. This digital-health synergy is enhancing the diagnostic workflow and improving health outcomes
- As healthcare systems shift toward value-based care and personalized medicine, the demand for capillary blood sampling that facilitates early detection and monitoring outside traditional clinical settings is surging. This trend is transforming diagnostic access, especially in underserved and rural populations
- Leading manufacturers are expanding their product lines with devices tailored for both professional and home use, with features such as single-use designs, reduced contamination risk, and compliance with regulatory standards for remote specimen collection
